$318 Million is the total value of WILKINS INVESTMENT COUNSEL INC's 74 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PG | Buy | Procter & Gamble | $10,179,000 | +9.3% | 130,394 | +11.0% | 3.20% | +8.8% |
NVS | Buy | Novartis AG (ADR) | $9,350,000 | -2.2% | 123,770 | +4.7% | 2.94% | -2.6% |
MDT | Buy | Medtronic PLC | $8,432,000 | +6.8% | 98,495 | +0.1% | 2.65% | +6.3% |
PEP | Buy | PepsiCo | $7,654,000 | +14.3% | 70,307 | +14.6% | 2.41% | +13.7% |
CB | Buy | Chubb Limited | $7,261,000 | -2.8% | 57,164 | +4.6% | 2.28% | -3.3% |
TRMB | Buy | Trimble | $5,649,000 | -6.9% | 172,025 | +1.7% | 1.78% | -7.3% |
FAST | Buy | Fastenal | $5,146,000 | -11.4% | 106,925 | +0.5% | 1.62% | -11.9% |
LOGM | Buy | LogMeIn | $4,808,000 | -5.1% | 46,565 | +6.2% | 1.51% | -5.6% |
XOM | Buy | Exxon Mobil | $4,531,000 | +11.5% | 54,770 | +0.6% | 1.43% | +11.0% |
WMB | Buy | Williams Cos | $4,146,000 | +22.4% | 152,950 | +12.2% | 1.30% | +21.7% |
WY | Buy | Weyerhaeuser | $3,687,000 | +4.4% | 101,125 | +0.2% | 1.16% | +3.9% |
T | Buy | AT&T | $3,252,000 | 0.0% | 101,288 | +11.0% | 1.02% | -0.5% |
VZ | Buy | Verizon | $1,673,000 | +7.0% | 33,250 | +1.7% | 0.53% | +6.7% |
TXN | Buy | Texas Instruments | $1,552,000 | +10.1% | 14,080 | +3.7% | 0.49% | +9.6% |
CERN | Buy | Cerner Corp | $1,288,000 | +19.0% | 21,550 | +15.5% | 0.40% | +18.4% |
CMCSA | Buy | Comcast Corp | $1,142,000 | -1.7% | 34,812 | +2.4% | 0.36% | -2.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Merck | 42 | Q3 2023 | 5.7% |
Newmont Mining | 42 | Q3 2023 | 7.2% |
Procter & Gamble | 42 | Q3 2023 | 4.9% |
Intel | 42 | Q3 2023 | 5.0% |
Johnson & Johnson | 42 | Q3 2023 | 3.7% |
International Flavors & Fragra | 42 | Q3 2023 | 4.2% |
Automatic Data Processing | 42 | Q3 2023 | 3.9% |
Sysco | 42 | Q3 2023 | 4.2% |
Northern Trust | 42 | Q3 2023 | 4.0% |
Novartis AG (ADR) | 42 | Q3 2023 | 3.7% |
View WILKINS INVESTMENT COUNSEL INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-10 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-09 |
View WILKINS INVESTMENT COUNSEL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.